Galenica Sante Ag Stock Shares Owned By Insiders
| GALE Stock | CHF 70.55 0.55 0.79% |
Galenica Sante AG fundamentals help investors to digest information that contributes to Galenica Sante's financial success or failures. It also enables traders to predict the movement of Galenica Stock. The fundamental analysis module provides a way to measure Galenica Sante's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Galenica Sante stock.
Galenica |
Galenica Sante AG Company Shares Owned By Insiders Analysis
Galenica Sante's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Galenica Sante Shares Owned By Insiders | 0.17 % |
Most of Galenica Sante's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Galenica Sante AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 0.17% of Galenica Sante AG are shares owned by insiders. This is 98.88% lower than that of the Healthcare sector and 98.8% lower than that of the Biotechnology industry. The shares owned by insiders for all Switzerland stocks is 98.32% higher than that of the company.
Galenica Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galenica Sante's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Galenica Sante could also be used in its relative valuation, which is a method of valuing Galenica Sante by comparing valuation metrics of similar companies.Galenica Sante is currently under evaluation in shares owned by insiders category among related companies.
Galenica Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0492 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.26 B | |||
| Shares Outstanding | 49.64 M | |||
| Shares Owned By Insiders | 0.17 % | |||
| Shares Owned By Institutions | 49.77 % | |||
| Price To Earning | 16.37 X | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 0.94 X | |||
| Revenue | 3.83 B | |||
| Gross Profit | 427.92 M | |||
| EBITDA | 305.98 M | |||
| Net Income | 167.68 M | |||
| Cash And Equivalents | 164.98 M | |||
| Cash Per Share | 2.13 X | |||
| Total Debt | 579.88 M | |||
| Debt To Equity | 43.80 % | |||
| Current Ratio | 1.77 X | |||
| Book Value Per Share | 23.35 X | |||
| Cash Flow From Operations | 333.1 M | |||
| Earnings Per Share | 3.45 X | |||
| Target Price | 70.0 | |||
| Number Of Employees | 5.52 K | |||
| Beta | 0.19 | |||
| Market Capitalization | 3.74 B | |||
| Total Asset | 2.57 B | |||
| Z Score | 4.6 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 2.57 B | |||
| Last Dividend Paid | 2.1 |
About Galenica Sante Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Galenica Sante AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galenica Sante using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galenica Sante AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galenica Sante AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Galenica Stock analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |